您的购物车当前为空
别名 林妥珠单抗, SGN-33, SGN33, HuM-195, HuM195
Lintuzumab (HuM-195) 是一种针对细胞表面骨髓单核细胞分化抗原 CD33 的非偶联人源化小鼠单克隆抗体,具有抗白血病活性,可减少 AML 细胞产生 TNFα 诱导的促炎细胞因子和趋化因子。Lintuzumab 具有抗肿瘤活性,通过 CDC 或者 ADCC 直接诱导细胞死亡。
Lintuzumab (HuM-195) 是一种针对细胞表面骨髓单核细胞分化抗原 CD33 的非偶联人源化小鼠单克隆抗体,具有抗白血病活性,可减少 AML 细胞产生 TNFα 诱导的促炎细胞因子和趋化因子。Lintuzumab 具有抗肿瘤活性,通过 CDC 或者 ADCC 直接诱导细胞死亡。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,230 | In stock | |
| 5 mg | ¥ 3,230 | In stock | |
| 10 mg | ¥ 4,790 | In stock | |
| 25 mg | ¥ 7,360 | In stock |
Lintuzumab 相关产品
| 产品描述 | Lintuzumab (HuM-195) is a non-coupled humanized mouse monoclonal antibody directed against the cell-surface myelomonocyte differentiation antigen, CD33, with anti-leukemic activity that reduces the production of TNFα-induced pro-inflammatory cytokines and chemokines by AML cells.Lintuzumab has antitumor activity and induces cell death directly via CDC or ADCC. Lintuzumab has anti-tumor activity and induces cell death directly via CDC or ADCC. |
| 别名 | 林妥珠单抗, SGN-33, SGN33, HuM-195, HuM195 |
| CAS No. | 166089-32-3 |
| 密度 | no data available |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容